Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications hifmech study group plasminogen activator inhibitor 1 675 4g5g genotype influences risk
IPECAD Cross Comparison Challenge on Cost-Effectiveness Models in Alz Disease and Related Dementias William L Herring, PhD Executive Director, Health Economics Transcript As disease-modifying therapies for Alzheimer’s disease, or AD, enter the market, …
… is a Director in the Surveys and Observational Studies group at RTI-HS. She has more than 19 years of project … post authorization safety studies (PASS), risk evaluation and mitigation strategy (REMS) assessment … diseases. Ms. Sweeney's project experience includes study design and implementation protocol development, …
… differences between the population in the pivotal clinical study (e.g., stage of disease) and the population that … of the PRO instrument should be clearly specified in a study protocol and statistical analysis plan and should … will vary based on whether the instrument supports a study’s primary endpoint, inclusion criteria, or a safety …
… Alicia Abellan Pharmacoepidemiology and Risk Management Barcelona, Spain PhD, Biomedicine Pompeu … in the Pharmacoepidemiology and Risk Management group with RTI-HS. Dr. Abellan has a background in … and performing epidemiologic studies using diverse study designs and data sources, including multidatabase …
… the Medical Writing, Editing, and Design Services (MEDS) group with RTI-HS. Dr. Lopez collaborates with researchers across therapeutic fields to plan and develop publications highlighting their work. Key research fields and … Lopez conducted research examining how the gut microbiota influences inflammatory bowel disease complications at the …
Autoimmune Diseases A Wealth of Experience We have collaborated with our clients on projects to research autoimmune diseases, autoimmune treatments, and complications and comorbidities of autoimmune disorders. Our experience includes: Celiac disease …
… terms or words with a troubling history, such as “at risk” to describe communities, individuals, and patients. Instead, “at risk” should be used to describe specific conditions or … that people experience (for example, patients at risk of developing diabetes; Black patients at risk of …
Diabetes & Endocrine Disorders A Wealth of Experience We have collaborated with our clients on projects to research diabetes and endocrine disorders, diabetes and endocrine treatments, and complications and comorbidities of diabetes and endocrine …
Ophthalmology A Wealth of Experience We have collaborated with our clients on projects to research ocular disease, ocular treatment, and complications and comorbidities of ocular disease. Our experience includes: Benign essential blepharospasm (BEB) …
… analysis Our Approach From design to deliverables, publications , and ongoing support, we develop and validate … and transparent model Developing documents and publications to communicate the value of your product …